Core Insights - In the first half of 2025, Brazil's pharmaceutical sales reached 138.3 billion reais (approximately 25.479 billion USD), marking an 11.5% year-on-year growth [1] - 78% of the pharmaceuticals sold in Brazil are produced locally, indicating a strong domestic manufacturing presence [1] - The average price of pharmaceuticals in Brazil increased by 5% at the beginning of the year, contributing to the industry's growth [1] Industry Growth - Over the past 25 years, the pharmaceutical industry in Brazil has seen a sales increase of 180%, with a 19% growth in sales since 2020 [1] - The highest sales volume within the pharmaceutical segment comes from generic drugs, reflecting a significant market trend [1] Market Dynamics - In the year 2000, following the enactment of the generic drug law, fewer than 5,000 drugs were registered with Brazil's health regulatory agency (Anvisa), whereas the current number exceeds 17,000 [1] - Local pharmaceutical companies are capturing a larger market share due to technological advancements and increasing market demand [1] - The market share of foreign companies is currently only 20%, primarily consisting of branded drugs, and is expected to decline to 10% by 2030 [1]
2025年上半年巴西药品销售额同比增长11.5%
Shang Wu Bu Wang Zhan·2025-09-06 17:51